The Particle Therapy Global Market Report 2023, provides comprehensive information on the particle therapy market across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Particle Therapy Market’s Growth:
https://www.thebusinessresearchcompany.com/report/particle-therapy-global-market-report
The global particle therapy market is expected to grow from $0.98 billion in 2022 to $1.11 billion in 2023 at a compound annual growth rate (CAGR) of 13.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global particle therapy is expected to reach $1.74 billion in 2027 at a CAGR of 11.9%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12250&type=smp
Advanced particle therapy platforms are a key trend gaining popularity in the particle therapy market. Major companies operating in the particle therapy market are developing innovative particle therapy platforms to sustain their position in the market. For instance, in October 2021, Ion Beam Applications S.A. (IBA), a Belgium-based medical technology company, launched the world’s first online proton therapy platform. This innovative web-based platform provides users access to a wide range of resources, including proton therapy educational materials, discussion forums, and clinical trials. The platform also features a virtual reality (V.R.) tour of a proton therapy center, which allows users to experience what it is like to receive proton therapy. Additionally, this platform provides users access to a wide range of information about proton therapy. It is a valuable tool for clinicians, researchers, and patients working to improve the lives of people with cancer.
The particle therapy market is segmented:
1) By Type: Proton Therapy, Heavy Ion Therapy
2) By System: Single-Room Systems, Multi-Room Systems
3) By Cancer Type: Pediatric Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Brain And Spinal Cord Cancer, Other Cancer Types
4) By End-User: Hospital, Academic And Research Centers
Top Major Players:
Hitachi Ltd
Mitsubishi Electric Corporation
Siemens Healthineers AG
Koninklijke Philips N.V
GE Healthcare
North America was the largest region in the particle therapy market in 2022
.
The table of contents in TBRC’s particle therapy market report includes:
1. Executive Summary
2. Particle Therapy Market Characteristics
3. Particle Therapy Market Trends And Strategies
4. Particle Therapy Market - Macro Economic Scenario
5.Global Particle Therapy Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
……………………………………………………………………………………….
32. Global Particle Therapy Market Competitive Benchmarking
33. Global Particle Therapy Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Particle Therapy Market
35. Particle Therapy Market Future Outlook and Potential Analysis
36. Appendix
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Read Related Reports:
https://topprnews.com/monolithic-microwave-ic-market/
https://goodprnews.com/monolithic-microwave-ic-market/
https://topprnews.com/network-switches-market/
https://goodprnews.com/network-switches-market/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn:https://in.linkedin.com/company/the-business-research-company
Twitter:https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Healthcare Blog:https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The study involved four major activities to estimate the current market size for particle therapy.
Exhaustive secondary research was done to collect information on the market and its different subsegments.
The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.Both top-down and bottom-up approaches were employed to estimate the complete market size.
Thereafter market breakdown and data triangulation was used to estimate the market size of segments and subsegments.Major Growth Drivers:Growth in the particle therapy market is primarily driven by factors such as the various advantages offered by particle therapy over photon therapy, growing global prevalence of cancer, increasing adoption of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide.Expected Revenue Growth:The particle therapy market is projected to grow from an estimated USD 865 million in 2018 to USD 1,349 million by 2023, at a CAGR of 9.3% during the forecast period.Synchrotrons are used to accelerate both protons and heavy ions such as carbon and hydrogen.
The growth of the synchrotrons segment is attributed to factors such as the increasing number of research activities as well as the increasing investments in the development of synchrotron facilities.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12809137The large share of the proton therapy segment can be attributed to factors such as the high degree of precision, shorter treatment time, and reduced side-effects associated with proton therapy as compared to conventional photon therapies using X-rays.
Other factors such as the increasing research activities in the field of radiation oncology using proton therapy systems, rising number of proton therapy centers, and longer equipment lifespan of proton therapy (30 years or more) in comparison to photon therapy (10 years) are expected to support the growth of this market in the coming years.The introduction of small footprint single-room particle therapy centers is further promoting the adoption of proton therapy for the treatment of cancer in small-scale hospitals.
